Difficulty: Medium
Average Score: 75%
Practice
A 72-year-old man is brought to his physician by his son. The son complains that this patient has been becoming forgetful, confused, moody, and aggressive over the past few months. Which of the following neurotransmitter changes is characteristic of Alzheimer's disease?
Correct answer
A
Rationale
In Alzheimer's disease, there is a characteristic decrease in acetylcholine levels in the brain. Acetylcholine is a neurotransmitter that plays a crucial role in memory, learning, and cognitive functions. The decline in acetylcholine levels contributes to the cognitive decline seen in Alzheimer's patients.
Option A, decreased acetylcholine, is the correct answer because it aligns with the known pathophysiology of Alzheimer's disease. Options B and C, decreased dopamine and norepinephrine, are not typically associated with Alzheimer's disease. Dopamine is more related to movement and reward pathways, while norepinephrine is involved in the body's stress response.
Option D, increased acetylcholine, is also incorrect as Alzheimer's disease is characterized by a decrease, not an increase, in acetylcholine levels. Understanding these neurotransmitter changes in Alzheimer's disease is vital for healthcare professionals to provide appropriate pharmacological interventions to manage symptoms and potentially slow down disease progression.
Option A, decreased acetylcholine, is the correct answer because it aligns with the known pathophysiology of Alzheimer's disease. Options B and C, decreased dopamine and norepinephrine, are not typically associated with Alzheimer's disease. Dopamine is more related to movement and reward pathways, while norepinephrine is involved in the body's stress response.
Option D, increased acetylcholine, is also incorrect as Alzheimer's disease is characterized by a decrease, not an increase, in acetylcholine levels. Understanding these neurotransmitter changes in Alzheimer's disease is vital for healthcare professionals to provide appropriate pharmacological interventions to manage symptoms and potentially slow down disease progression.